Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 38 studies | 41% ± 12% | |
memory B cell | 19 studies | 46% ± 14% | |
naive B cell | 19 studies | 32% ± 10% | |
immature B cell | 6 studies | 40% ± 13% | |
precursor B cell | 4 studies | 34% ± 5% | |
germinal center B cell | 3 studies | 36% ± 6% |
Insufficient scRNA-seq data for expression of BLK at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 88% | 145.22 | 507 / 578 | 43% | 1.72 | 494 / 1155 |
lymph node | 0% | 0 | 0 / 0 | 100% | 73.67 | 29 / 29 |
spleen | 100% | 7371.44 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 2722.05 | 922 / 929 | 0% | 0 | 0 / 0 |
stomach | 65% | 128.48 | 233 / 359 | 24% | 1.09 | 70 / 286 |
liver | 82% | 74.11 | 186 / 226 | 6% | 0.61 | 25 / 406 |
kidney | 65% | 190.27 | 58 / 89 | 6% | 0.26 | 55 / 901 |
intestine | 54% | 1395.90 | 517 / 966 | 17% | 1.47 | 92 / 527 |
thymus | 44% | 210.73 | 285 / 653 | 25% | 1.48 | 152 / 605 |
tonsil | 0% | 0 | 0 / 0 | 53% | 2.68 | 24 / 45 |
esophagus | 25% | 68.26 | 357 / 1445 | 22% | 1.03 | 40 / 183 |
breast | 26% | 26.00 | 119 / 459 | 20% | 0.89 | 219 / 1118 |
prostate | 35% | 84.18 | 85 / 245 | 11% | 0.32 | 54 / 502 |
bladder | 29% | 49.95 | 6 / 21 | 16% | 1.30 | 79 / 504 |
skin | 17% | 14.37 | 299 / 1809 | 27% | 2.03 | 129 / 472 |
pancreas | 1% | 0.86 | 4 / 328 | 38% | 3.36 | 67 / 178 |
adipose | 26% | 39.99 | 312 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 20% | 13.23 | 52 / 258 | 6% | 0.10 | 13 / 230 |
uterus | 3% | 2.14 | 5 / 170 | 9% | 0.29 | 42 / 459 |
ovary | 5% | 3.29 | 9 / 180 | 6% | 0.20 | 27 / 430 |
eye | 0% | 0 | 0 / 0 | 10% | 0.23 | 8 / 80 |
brain | 0% | 0.27 | 8 / 2642 | 7% | 0.38 | 49 / 705 |
blood vessel | 7% | 31.23 | 96 / 1335 | 0% | 0 | 0 / 0 |
heart | 5% | 5.95 | 39 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.25 | 2 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0032092 | Biological process | positive regulation of protein binding |
GO_0050853 | Biological process | B cell receptor signaling pathway |
GO_0018108 | Biological process | peptidyl-tyrosine phosphorylation |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0006468 | Biological process | protein phosphorylation |
GO_0030154 | Biological process | cell differentiation |
GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
GO_0032024 | Biological process | positive regulation of insulin secretion |
GO_0045087 | Biological process | innate immune response |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0004713 | Molecular function | protein tyrosine kinase activity |
GO_0004715 | Molecular function | non-membrane spanning protein tyrosine kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | BLK |
Protein name | Tyrosine-protein kinase Blk (EC 2.7.10.2) (B lymphocyte kinase) (p55-Blk) Tyrosine-protein kinase (EC 2.7.10.2) |
Synonyms | |
Description | FUNCTION: Non-receptor tyrosine kinase involved in B-lymphocyte development, differentiation and signaling (By similarity). B-cell receptor (BCR) signaling requires a tight regulation of several protein tyrosine kinases and phosphatases, and associated coreceptors (By similarity). Binding of antigen to the B-cell antigen receptor (BCR) triggers signaling that ultimately leads to B-cell activation (By similarity). Signaling through BLK plays an important role in transmitting signals through surface immunoglobulins and supports the pro-B to pre-B transition, as well as the signaling for growth arrest and apoptosis downstream of B-cell receptor (By similarity). Specifically binds and phosphorylates CD79A at 'Tyr-188'and 'Tyr-199', as well as CD79B at 'Tyr-196' and 'Tyr-207' (By similarity). Phosphorylates also the immunoglobulin G receptors FCGR2A, FCGR2B and FCGR2C . With FYN and LYN, plays an essential role in pre-B-cell receptor (pre-BCR)-mediated NF-kappa-B activation (By similarity). Contributes also to BTK activation by indirectly stimulating BTK intramolecular autophosphorylation (By similarity). In pancreatic islets, acts as a modulator of beta-cells function through the up-regulation of PDX1 and NKX6-1 and consequent stimulation of insulin secretion in response to glucose . Phosphorylates CGAS, promoting retention of CGAS in the cytosol . . |
Accessions | P51451 ENST00000259089.9 Q05D26 ENST00000646615.3 |